BeStock  
Markets › Compare › SMCAY vs ALNY

SMCAY vs ALNY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SMCAY · SMC (ADR)$23.78 ▲ 0.76%
ALNY · Alnylam Pharmaceuticals$219.89 ▲ 0.08%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3869100131163Oct 7, '25Apr 7, '26Oct 5, '26
  • SMCAY +38.4%
  • ALNY -52.2%

Head to head

MetricSMCAYALNY
Price$23.78$219.89
Change today▲ 0.76%▲ 0.08%
Market cap$29.46B$29.42B
Return, 3 months+6.9%-31.6%
Return, year to date+37.8%-44.7%
Return, 1 year+37.0%-51.4%
P/E (TTM)27.338.3
P/B2.221.7
P/E percentile vs own 5y–84th
Dividend yield1.34%–
Revenue growth (YoY, latest qtr)–+66.9%
Net profit growth (YoY)–+327.7%
Gross margin–79.7%
Operating margin–20.8%
Net margin–16.1%
Return on equity–96.6%
Analyst target vs. price–+68.2%
Analyst buy share–86%
RSI (14)6434
30-day volatility38.5%45.8%
Max drawdown, 1 year-28.9%-58.2%
Trend readStrong uptrendStrong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • SMCAY is the largest of the group by market value.
  • SMCAY has returned the most over the past year.
  • SMCAY carries the lowest trailing P/E.
  • SMCAY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top